tradmap

ASND Ascendis Pharma A/S

$257.95 +3.22%

Data as of close

Healthcare · Pharmaceutical Preparations

Ascendis Pharma A/S (ASND) is a healthcare company in the Pharmaceutical Preparations industry. Shares last traded at $257.95, 8.5% below their 52-week high. Over the past year the stock is up 28.4%.

Market Cap
—
Shares Out
—
EPS (TTM) (per ord. share)
—
P/E (TTM)*
—
P/S Ratio
—
P/B Ratio
—
Dividend / ord. share
—
Dividend Yield
—
52-Week High
$281.76
52-Week Low
$188.94
Volume (venue)
40,356
Avg Vol (3m, venue)
45,571.714

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Ascendis Pharma A/S reports in EUR: EPS, dividends and financials are shown in EUR as filed, per ordinary share. There is no share count on file for the US listing (a depositary receipt prices at a ratio we do not source), so there is no market cap and no price ratio.

Performance

1W
+3.28%
1M
+14.03%
3M
+3.25%
6M
+9.35%
YTD
+20.94%
1Y
+28.36%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
68.94
SMA (50)
$242.32
SMA (200)
$238.71
Price vs SMA50
+6.45%
Price vs SMA200
+8.06%
ATR (14)
$6.19

Full technical analysis (26 indicators, D/W/M) →

Pharmaceutical Preparations peers

ASND vs 14 industry peers (Pharmaceutical Preparations), by market cap. Data as of close

1–14 of 14
LLYLilly (Eli)$1.33T48.3715.4331.9%+0.62%
JNJJohnson & Johnson$665.2B41.336.7016.2%+3.82%
ONCBeone Medicines Ltd.$558.0B850.9391.0410.7%+6.36%
ABBVAbbVie$521.3B50.407.9015.7%+3.16%
MRKMerck$370.7B151.125.503.6%+3.93%
ABTAbbott Laboratories$200.2B42.584.159.7%+5.61%
PFEPfizer$175.5B43.522.766.3%+2.70%
VRTXVertex Pharmaceuticals$139.2B35.0110.7530.7%+3.37%
BMYBristol Myers Squibb$131.2B14.202.6218.5%+4.04%
REGNRegeneron Pharmaceuticals$96.3B19.995.7028.5%-4.41%
TEVATeva Pharmaceutical Industries Ltd$48.8B96.392.832.9%-0.24%
ZTSZoetis$36.8B14.083.8727.5%+7.40%
RPRXRoyalty Pharma Plc$30.1B44.8011.5025.7%+1.82%
ROIVRoivant Sciences Ltd.$27.6B—3665.32—+5.99%

Source: SEC EDGAR (fundamentals/EPS/dividends, reported in EUR) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.